![Fresenius Kabi Introduces Glycopyrrolate Injection, USP Simplist® Prefilled Syringes in 0.2 mg per 1 mL and 0.4 mg per 2 mL Presentations | Business Wire Fresenius Kabi Introduces Glycopyrrolate Injection, USP Simplist® Prefilled Syringes in 0.2 mg per 1 mL and 0.4 mg per 2 mL Presentations | Business Wire](https://mms.businesswire.com/media/20190429005618/en/718716/5/Glycopyrrolate_Syringes_Group.jpg)
Fresenius Kabi Introduces Glycopyrrolate Injection, USP Simplist® Prefilled Syringes in 0.2 mg per 1 mL and 0.4 mg per 2 mL Presentations | Business Wire
![SPECIAL FEATURE - Prefilled Syringes & Parenteral Contract Manufacturing - Product Differentiation Is Critical SPECIAL FEATURE - Prefilled Syringes & Parenteral Contract Manufacturing - Product Differentiation Is Critical](https://d2akihtr51eb46.cloudfront.net/wp-content/uploads/2014/05/Unilife.jpg)
SPECIAL FEATURE - Prefilled Syringes & Parenteral Contract Manufacturing - Product Differentiation Is Critical
![Prefilled syringes: Key considerations for ready-to-use drug administration - Pharmaceutical Technology Prefilled syringes: Key considerations for ready-to-use drug administration - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2021/05/shutterstock_1140468401.jpg)